060280 — CUREXO Balance Sheet
0.000.00%
- KR₩363bn
- KR₩331bn
- KR₩56bn
Annual balance sheet for CUREXO, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6,007 | 7,576 | 21,081 | 34,783 | 33,481 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 11,480 | 13,011 | 18,513 | 22,985 | 16,266 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 39,064 | 50,471 | 75,952 | 90,831 | 87,942 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,372 | 1,864 | 2,741 | 6,638 | 7,852 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 48,879 | 61,306 | 98,398 | 107,370 | 102,583 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3,409 | 18,271 | 16,589 | 4,933 | 7,936 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 4,084 | 18,404 | 16,717 | 6,941 | 9,203 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 44,795 | 42,902 | 81,681 | 100,429 | 93,381 |
Total Liabilities & Shareholders' Equity | 48,879 | 61,306 | 98,398 | 107,370 | 102,583 |
Total Common Shares Outstanding |